Sarepta Therapeutics (SRPT) Amortization - Intangibles (2017 - 2026)
Sarepta Therapeutics (SRPT) recorded quarterly Amortization - Intangibles of $691000.0 in Q1 2026, up 2.07% quarter-over-quarter from $677000.0 in Q4 2025, and up 14.98% on a YoY basis from $601000.0 in Q1 2025.
Sarepta Therapeutics (SRPT) Amortization - Intangibles (2017 - 2026) Analysis & Trends
Sarepta Therapeutics' Amortization - Intangibles history runs 10 years deep, the most recent figure standing at $691000.0 for Q1 2026.
- In Q1 2026, Amortization - Intangibles rose 14.98% year-over-year to $691000.0; the TTM figure through Mar 2026 stood at $2.7 million (up 12.77% YoY), while the FY2025 annual figure was $2.6 million, up 9.02% from the prior year.
- Amortization - Intangibles was $691000.0 for Q1 2026 at Sarepta Therapeutics, up from $677000.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $763000.0 in Q4 2023 to a low of $178000.0 in Q1 2022.
- Historically, Amortization - Intangibles has averaged $470058.8 across 5 years, with a median of $601000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Amortization - Intangibles soared 326.26% in 2023, then fell 21.23% in 2024.
- A 5-year view of Amortization - Intangibles shows it stood at $179000.0 in 2022, then surged by 326.26% to $763000.0 in 2023, then dropped by 21.23% to $601000.0 in 2024, then gained by 12.65% to $677000.0 in 2025, then rose by 2.07% to $691000.0 in 2026.
- The last three Amortization - Intangibles figures came in at $691000.0 (Q1 2026), $677000.0 (Q4 2025), and $677000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sarepta Therapeutics | 1.84 Bn | 1.16 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 691,000.00 |
| Dec 31, 2025 | 677,000.00 |
| Sep 30, 2025 | 677,000.00 |
| Jun 30, 2025 | 667,000.00 |
| Mar 31, 2025 | 601,000.00 |
| Dec 31, 2024 | 601,000.00 |
| Sep 30, 2024 | 602,000.00 |
| Jun 30, 2024 | 601,000.00 |
| Mar 31, 2024 | 601,000.00 |
| Dec 31, 2023 | 763,000.00 |
| Sep 30, 2023 | 439,000.00 |
| Jun 30, 2023 | 179,000.00 |
| Mar 31, 2023 | 178,000.00 |
| Dec 31, 2022 | 179,000.00 |
| Sep 30, 2022 | 178,000.00 |
| Jun 30, 2022 | 179,000.00 |
| Mar 31, 2022 | 178,000.00 |
| Dec 31, 2021 | 179,000.00 |
| Sep 30, 2021 | 178,000.00 |
| Jun 30, 2021 | 179,000.00 |